Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
8.21
+0.11 (1.36%)
At close: Feb 6, 2026, 4:00 PM EST
8.16
-0.05 (-0.61%)
After-hours: Feb 6, 2026, 7:23 PM EST
Organon & Co. Market Cap
Organon & Co. has a market cap or net worth of $2.13 billion as of February 6, 2026. Its market cap has decreased by -49.49% in one year.
Market Cap
2.13B
Enterprise Value
10.29B
1-Year Change
-49.49%
Ranking
Category
Stock Price
$8.21
Market Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $2.13B, a decrease of -74.64%. That is a compound annual growth rate of -25.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 2.13B | 14.50% |
| Dec 31, 2025 | 1.86B | -51.49% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
| May 14, 2021 | 8.42B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pfizer | 154.76B |
| Bristol-Myers Squibb Company | 126.20B |
| GSK plc | 120.04B |
| Sanofi | 114.76B |
| Biogen | 29.52B |
| Grifols | 7.82B |
| Amarin Corporation | 306.69M |
| Scilex Holding Company | 52.02M |